Higher efficacy of pegylated interferon-α2b add-on therapy in hepatitis B envelope antigen-positive chronic hepatitis B patients on tenofovir monotherapy

2018 ◽  
Vol 48 (6) ◽  
pp. 451-458 ◽  
Author(s):  
Ankur Jindal ◽  
Ashish Kumar Vyas ◽  
Devesh Kumar ◽  
Guresh Kumar ◽  
Manoj Kumar Sharma ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Pegylated Interferon ◽  
Positive Chronic Hepatitis ◽  
Interferon Α2b ◽  
Envelope Antigen

Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype

2011 ◽  
Vol 17 (1) ◽  
pp. 9-17 ◽  
Author(s):  
Milan J Sonneveld ◽  
Vincent Rijckborst ◽  
Yilmaz Cakaloglu ◽  
Krzysztof Simon ◽  
E Jenny Heathcote ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Surface Antigen ◽  
Hepatitis B Surface Antigen ◽  
Pegylated Interferon ◽  
Hepatitis B E Antigen ◽  
Hbv Genotype ◽  
Positive Chronic Hepatitis ◽  
Interferon Α2b

scholarly journals Adding pegylated interferon to entecavir for hepatitis B e antigen-positive chronic hepatitis B: A multicenter randomized trial (ARES study)

Hepatology ◽  
2015 ◽  
Vol 61 (5) ◽  
pp. 1512-1522 ◽  
Author(s):  
Willem Pieter Brouwer ◽  
Qing Xie ◽  
Milan J. Sonneveld ◽  
Ningping Zhang ◽  
Qin Zhang ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Randomized Trial ◽  
Chronic Hepatitis B ◽  
Pegylated Interferon ◽  
Hepatitis B E Antigen ◽  
Multicenter Randomized Trial ◽  
Positive Chronic Hepatitis
Sign in / Sign up

Export Citation Format

Share Document